Calculating the outcome of pharma on canadian scientific research

Nearly two decades ago, Canada’s Patent Act was amended to more carefully reflect worldwide standards. Essential was enforced to yearly report pharmaceutical companies’ investments in Canadian development and research like a percent of Canadian pharmaceutical sales with the Patented Medicines Prices Review Board (PMPRB).

In those days, the funding of scientific research was essentially different than today. Within the late 1980’s and early 1990’s, state-of-the-art pharmaceutical companies operated massive in-house research operations and outsourced significant aspects of that research to universities and research institutions. Today, the catalyst for scientific research in Canada isn’t in-house spending by pharmaceutical giants but instead the investment capital the pharmaceutical industry yet others provide to aid many Canadian biotech firms that are the main thing on medical and pharmaceutical discovery.

Regardless of the significant purchase of biotech, the number of development and research spending like a proportion of Canadian pharmaceutical sales might be lower today than previously, however the trend to finance home-grown Canadian biotechnology comes with an a great deal larger impact compared to industry’s previous contributions to R&D.

Multi-national research-based pharmaceutical information mill the main catalyst for indirect and direct funding of Canadian scientific research. Canadian medical innovation and the development of cutting–edge research jobs originates from countless small health-related biotech companies. These businesses exist and flourish due to their capability to attract investment capital which investment capital exists mainly due to the prospect of partnerships or acquisitions by innovative multinational pharmaceutical companies.

For instance, captured Northern Biologics, a little Canadian company, received an upfront payment of $$ 30 million and the opportunity of additional payments from Celgene, a sizable multi-national pharmaceutical company. This Year, US based multi-national Alexion acquired Enobia, a little Canadian biotech for pretty much $1 billion. They are significant investments within the outputs of Canadian scientific research that should never be taken in R&D to sales ratio statistics.

Similarly, Charles River Laboratories’ massive purchase of Quebec, and also the nearly 2,000 highly trained jobs that that entails, happens because Charles River provides contract searching for major pharmaceutical companies around the globe. Again, a substantial positive effect on Canadian scientific research not taken through the R&D to sales statistic.

Canada’s outdated, and possibly largely irrelevant, requirement to report R&D expenses like a percent of sales through Patented Medicines Prices Review Board (PMPRB) doesn’t reflect a realistic look at the Canadian development and research atmosphere. Start-ups, investment capital, and acquisitions would be the norm for those R&D based industries including bio-pharmaceutical.

In Canada small biotech information mill driving understanding-based industrial growth. To prosper these companies rely on investment capital that flows both directly and not directly from the possibilities of commercialization handles large multi-national pharmaceutical companies. Occasions have altered and just how we appraise the bio pharmaceutical sector’s contribution to the financial state must reflect modern realities.

Nearly sixty-six per cent of Canadian biotechnology is in healthcare and medicines. In a nutshell, medical innovation in Canada is vibrant. The Canadian research-based biotechnology sector contributes considerably when it comes to both employment and the introduction of existence-saving medicines used globally.

Marketing to Doctors: Last Week Tonight with John Oliver (HBO)

Video COMMENTS:

Matthew Carson: Every time I watch this show I feel more educated about the world around me and yet also severely more depressed about it.﻿

Zachary Brundidge: Literally the summary of this show﻿

Kevin De Souza: Americans used to make sense to me.\nThen I met John Oliver﻿

Katie Morris: Eli Hough – A recent study in 2016 showed that those countries that have a Monarchy rather than a President are monumentally more Free in terms of thought, speech and expression than those with a single authority in charge. Examples include Britain, Scandinavia, Belgium and Luxembourg.﻿

political kid: Katie Morris i shall keep this into accountability﻿

THRILLHO: "Last Week Tonight with John Oliver" or: "Everything In The USA Is Irreparably Fucked No Seriously with John Oliver"﻿

Zeno Bonk: Dustin Rausch the US is fucked up, so there isnt much good he can talk about, can he now﻿

spencer: "Sad Fact Hour with Johnny Rat-face"﻿

Adrian Jutronich: As a Doctor, I take the samples, read their material and then form my own opinion. If a patient asks me "What Brand of Vitamins is right for me", I answer, "They're all equally ineffective if you keep a good healthy diet, plus, no Big Pharma is paying me to recommend a particular one. Honestly, they're all the same." Problem is, I drive a shitty car and buy my own lunches. And having integrity has given me 0% profit over colleagues who take all these perks. The people doesn't give a fuck.\n\nI want to be a thought leader… and a Lexus :(﻿

Sara L: keep doing what you're doing it's very respectable and more people should be like you﻿

Stefano DrSAM: This is one good thing of Europe… commercials about prescription drugs are not allowed, the doctor decides what to prescribe to you, not the patient after watching a commercial.\n\nOnly prescription-free self medication ads are allowed.﻿

StYxXx: +Stefano DrSAM Well it's happening here too. Not that much or not that obvious. But free samples or other "gifts" are common. Even if not allowed. There were cases where pharma companies bought computers and stuff for a doctor and it wasn't clear if that already qualifies als "bribing". Then of course the insurance companies have special deals with some companies. But yeah, it's not like in the US. Or at least not yet. The USA sometimes looks like some scifi parody.﻿

Ann Nee: How is it that every time I watch this show I end up screaming in my head: "How can this possibly be legal?"﻿

Charles Robinson: +TovChapaev There is nothing inherently wrong with capitalism. Problems arise when the system is abused. Or neglected in this case﻿

Undertaker9711: A doctor once tried to prescribe me Depicote for chronic headaches. My brother takes that for his bi-polar disorder, its an anti-psychotic drug. Needless to say, i didnt take it and found a different doctor﻿